Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.
Soond SM, Chantry A.
Oncogene. 2011 May 26;30(21):2451-62. Epub 2011 Jan 24.
Related citations
SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation.
Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isshiki K, Isono M, Uzu T, Guarente L, Kashiwagi A, Koya D.
J Biol Chem. 2007 Jan 5;282(1):151-8. Epub 2006 Nov 10.
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.
Monteleone G, Del Vecchio Blanco G, Monteleone I, Fina D, Caruso R, Gioia V, Ballerini S, Federici G, Bernardini S, Pallone F, MacDonald TT.
Gastroenterology. 2005 Nov;129(5):1420-9.
AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F, Seo SR, Ferrand N, Pessah M, L'Hoste S, Rawadi G, Roman-Roman S, Camonis J, Atfi A.
J Biol Chem. 2005 Jul 29;280(30):27645-53. Epub 2005 Jun 8.
The balance between acetylation and deacetylation controls Smad7 stability.
Simonsson M, Heldin CH, Ericsson J, Grönroos E.
J Biol Chem. 2005 Jun 10;280(23):21797-803. Epub 2005 Apr 13.
Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K.
Oncogene. 2004 Sep 9;23(41):6914-23.
Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K.
J Biol Chem. 2001 Apr 20;276(16):12477-80. Epub 2001 Feb 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on